Cargando…
Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer
BACKGROUND: Daily adaptive radiation therapy (ART) of patients with non-small cell lung cancer (NSCLC) lowers organs at risk exposure while maintaining the planning target volume (PTV) coverage. Thus, ART allows an isotoxic approach with increased doses to the PTV that could improve local tumor cont...
Autores principales: | Hoppen, Lea, Sarria, Gustavo R., Kwok, Chung S., Boda-Heggemann, Judit, Buergy, Daniel, Ehmann, Michael, Giordano, Frank A., Fleckenstein, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945670/ https://www.ncbi.nlm.nih.gov/pubmed/36814271 http://dx.doi.org/10.1186/s13014-023-02222-7 |
Ejemplares similares
-
Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
por: Eckl, Miriam, et al.
Publicado: (2021) -
Cone Beam CT-Based Daily Adaptive Planning or Defined-Filling Protocol for Neoadjuvant Gastric Cancer Radiation Therapy: A Comparison
por: Sarria, Gustavo R., et al.
Publicado: (2020) -
Overall survival after reirradiation of spinal metastases – independent validation of predictive models
por: Buergy, Daniel, et al.
Publicado: (2016) -
Surface guidance compared with ultrasound-based monitoring and diaphragm position in cone-beam computed tomography during abdominal stereotactic radiotherapy in breath-hold
por: Kaestner, Lena, et al.
Publicado: (2023) -
Motion Management in a Patient With Tracheostomy During Lung Stereotactic Body Radiation Therapy: Breath Hold Is Worth a Try
por: Kaestner, Lena, et al.
Publicado: (2022)